• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Advisory Committees

  • Print
  • Share
  • E-mail

Slides for the May 12, 2010 Joint Meeting of the Arthritis Advisory Committee and the Drug Safety and Risk Management Advisory Committee

 

Persons with disabilities having problems accessing the PDF file(s) below may call (301) 796-3634 for assistance

 

FDA

  

FDA Core Presentation, Naproxcinod, for the May 12, 2010 Joint Meeting of the Arthritis Advisory Committee and the Drug Safety and Risk Management Advisory Committee (PDF – 1.30MB)

 

 

NicOx S.A.

 

NicOx Core Presentation, Naproxcinod, for the May 12, 2010 Joint Meeting of the Arthritis Advisory Committee and the Drug Safety and Risk Management Advisory Committee (PDF – 496KB)

 

NicOx Back-Up Presentation, Naproxcinod, for the May 12, 2010 Joint Meeting of the Arthritis Advisory Committee and the Drug Safety and Risk Management Advisory Committee (PDF – 93.1KB)